Evotec stands firm in tough environment
Evotec OAI has posted a strong set of figures in the first half of 2003 as operating losses are trimmed by a third and EBITDA enters positive territory.
Archives for August 11, 2003
Serum stripper aids in biomarker discovery
Agilent launches two new products at the ongoing Drug Discovery Technology meeting, including an LC column to remove high-abundance proteins from serum and an oligonucleotide mouse microarray to aid in toxicogenomics research.
USA speeds generic approvals
The pharmaceutical industry is facing the possibility of earlier generic competition for its branded products from 18 August, when new legislation in the USA comes into effect.
Merck buys into microarray market
Merck KGaA buys ProteoPlex in a move designed to shore up its position in the emerging microarray market, estimated to reach $2 billion (€1.76bn) in 2008.
Forget cloning, try sloning
Sloning BioTechnology is to receive grants totalling more than €1 million to help it commercialise new technologies in fully-automated gene synthesis.